LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Akeso Biomedical, Inc.…

Akeso Biomedical, Inc. Tech Stack

Akeso Biomedical, Inc. uses 8 technology products and services including Google Workspace, Google Fonts API, Google Tag Manager, and more. Explore Akeso Biomedical, Inc.'s tech stack below.

  • Google Workspace
    Email
  • Google Fonts API
    Font Scripts
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers
  • Nginx
    Web Servers
  • OpenResty
    Web Servers

Akeso Biomedical, Inc.'s Email Address Formats

Akeso Biomedical, Inc. uses at least 1 format(s):
Akeso Biomedical, Inc. Email FormatsExamplePercentage
FLast@akesobiomedical.comJDoe@akesobiomedical.com
40%
First.Last@akesobiomedical.comJohn.Doe@akesobiomedical.com
10%
FLast@akesobiomedical.comJDoe@akesobiomedical.com
40%
First.Last@akesobiomedical.comJohn.Doe@akesobiomedical.com
10%

Frequently Asked Questions

Where is Akeso Biomedical, Inc.'s headquarters located?

Minus sign iconPlus sign iconAkeso Biomedical, Inc.'s main headquarters is located at 850 Winter Street Waltham, Massachusetts 02451 United States. The company has employees across 1 continents, including North America.

What is Akeso Biomedical, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Akeso Biomedical, Inc.'s main corporate office by phone at
+1-781-890-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Akeso Biomedical, Inc.'s official website and social media links?

Minus sign iconPlus sign iconAkeso Biomedical, Inc.'s official website is akesobiomedical.com and has social profiles on LinkedInCrunchbase.

What is Akeso Biomedical, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconAkeso Biomedical, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Akeso Biomedical, Inc. have currently?

Minus sign iconPlus sign iconAs of February 2026, Akeso Biomedical, Inc. has approximately 2 employees across 1 continents, including North America. Key team members include Chief Executive Officer: S. W.. Explore Akeso Biomedical, Inc.'s employee directory with LeadIQ.

What industry does Akeso Biomedical, Inc. belong to?

Minus sign iconPlus sign iconAkeso Biomedical, Inc. operates in the Biotechnology Research industry.

What technology does Akeso Biomedical, Inc. use?

Minus sign iconPlus sign iconAkeso Biomedical, Inc.'s tech stack includes Google WorkspaceGoogle Fonts APIGoogle Tag ManagerGoogle AnalyticsApacheApache HTTP ServerNginxOpenResty.

What is Akeso Biomedical, Inc.'s email format?

Minus sign iconPlus sign iconAkeso Biomedical, Inc.'s email format typically follows the pattern of FLast@akesobiomedical.com. Find more Akeso Biomedical, Inc. email formats with LeadIQ.

How much funding has Akeso Biomedical, Inc. raised to date?

Minus sign iconPlus sign icon As of February 2026, Akeso Biomedical, Inc. has raised $574K in funding. The last funding round occurred on Feb 12, 2021 for $574K.

When was Akeso Biomedical, Inc. founded?

Minus sign iconPlus sign iconAkeso Biomedical, Inc. was founded in 2014.

Akeso Biomedical, Inc.

Biotechnology ResearchMassachusetts, United States2-10 Employees

Akeso Biomedical, Inc. is an early stage company focused on developing new solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds. The Company is developing products to treat these conditions using a new class of compounds, known as Fe3C, that have broad-spectrum activity against a wide range of bacteria, and a silk biomaterial technology exclusively licensed from Tufts University.

Akeso’s lead Fe3C product is a feed additive designed to prevent food poisoning by Campylobacter, a bacteria that causes more cases of foodborne illness in the EU than Salmonella, E. coli and Listeria combined, with an estimated 280,000 cases in the UK and 1.3 million cases in the US each year. The economic cost of treating patients infected with Campylobacter in the UK is reported to be $1.5 billion, and over $5.6 billion in the US.

Section iconCompany Overview

Headquarters
850 Winter Street Waltham, Massachusetts 02451 United States
Phone number
+1-781-890-****
Website
akesobiomedical.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $574K

    Akeso Biomedical, Inc. has raised a total of $574K of funding over 5 rounds. Their latest funding round was raised on Feb 12, 2021 in the amount of $574K.

  • $1M

    Akeso Biomedical, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $574K

    Akeso Biomedical, Inc. has raised a total of $574K of funding over 5 rounds. Their latest funding round was raised on Feb 12, 2021 in the amount of $574K.

  • $1M

    Akeso Biomedical, Inc.'s revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    S. W.
    Chief Executive Officer
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.